Implementation of Enhanced Recovery After Surgery Program (ERAS) in Colorectal Cancer Surgery, a Randomized Controlled Trial

Cancer of Colon Clinical Trial

Official title:

Enhanced Recovery After Surgery Program (ERAS) in Colorectal Cancer Surgery

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03928678
• Other study ID #: 458
• Status: Completed
• Phase: N/A
• Start date: May 1, 2019
• Est. completion date: December 1, 2020

Study information

• Verified date: April 2020
• Source: Assiut University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of our study is to determine the effect of implementation of the ERAS (enhanced recovery after surgery) protocol in our institute and its impact on hospital length of stay and outcome of surgery.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: December 1, 2020
• Est. primary completion date: November 1, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• Age = 60 years,

• Good nutrition,

• No systemic infection and

• Elective laparoscopic surgery

Exclusion Criteria:

• Age >75 years,

• Malnutrition or an organ system infection

• Associated with obstruction, bleeding, emergency surgery or other surgical intervention

• Tumor with extensive metastasis

• Prior to surgery, patient was fasting, underwent gastrointestinal decompression and received nutritional support

• Previous history of abdominal surgery

• Patient have previously undergone gastrostomy

Related Conditions & MeSH terms

• Cancer of Colon
• Colonic Neoplasms

Intervention

Procedure:
• enhanced recovery after surgery program in colorectal cancer surgery
to determine the feasibility of implementation of the ERAS protocol in our institute and its impact on hospital length of stay and outcome of surgery.

Locations

Country	Name	City	State
Egypt	South Egypt Cancer Instuite	Assuit

Sponsors (1)

Lead Sponsor	Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	length of hospital stay in days	length of hospital stay in days	4 days